{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:02:48Z","timestamp":1783940568421,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s00292-011-1442-2","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T19:51:40Z","timestamp":1316548300000},"page":"391-398","source":"Crossref","is-referenced-by-count":15,"title":["HPV-assoziierte Plattenepithelkarzinogenese","HPV-associated squamous cell carcinogenesis"],"prefix":"10.1007","volume":"32","author":[{"given":"G.","family":"Assmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sotlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,21]]},"reference":[{"key":"1442_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/vim.2006.19.481","volume":"19","author":"Alcocer-Gonzalez","year":"2006","unstructured":"Alcocer-Gonzalez JM, Berumen J, Tamez-Guerra R et al (2006) In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells. Viral Immunol 19:481\u2013491","journal-title":"Viral Immunol"},{"key":"1442_CR2","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1128\/JVI.65.5.2254-2260.1991","volume":"65","author":"Bedell","year":"1991","unstructured":"Bedell MA, Hudson JB, Golub TR et al (1991) Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J Virol 65:2254\u20132260","journal-title":"J Virol"},{"key":"1442_CR3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/jir.2009.0075","volume":"29","author":"Beglin","year":"2009","unstructured":"Beglin M, Melar-New M, Laimins L (2009) Human papillomaviruses and the interferon response. J Interferon Cytokine Res 29:629\u2013635","journal-title":"J Interferon Cytokine Res"},{"key":"1442_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tim.2010.10.002","volume":"19","author":"Bodily","year":"2011","unstructured":"Bodily J, Laimins LA (2011) Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol 19:33\u201339","journal-title":"Trends Microbiol"},{"key":"1442_CR5","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1128\/JVI.00724-06","volume":"80","author":"Culp","year":"2006","unstructured":"Culp TD, Budgeon LR, Marinkovich MP et al (2006) Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol 80:8940\u20138950","journal-title":"J Virol"},{"key":"1442_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0042-6822(02)00143-5","volume":"307","author":"Day","year":"2003","unstructured":"Day PM, Lowy DR, Schiller JT (2003) Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307:1\u201311","journal-title":"Virology"},{"key":"1442_CR7","doi-asserted-by":"crossref","first-page":"14252","DOI":"10.1073\/pnas.0404229101","volume":"101","author":"Day","year":"2004","unstructured":"Day PM, Baker CC, Lowy DR et al (2004) Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A 101:14252\u201314257","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1442_CR8","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1128\/JVI.00552-07","volume":"81","author":"Day","year":"2007","unstructured":"Day PM, Thompson CD, Buck CB et al (2007) Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol 81:8784\u20138792","journal-title":"J Virol"},{"key":"1442_CR9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1099\/0022-1317-76-4-1057","volume":"76","author":"De","year":"1995","unstructured":"De Roda Husman AM, Walboomers JM, van den Brule AJ et al (1995) The use of general primers GP5 and GP6 elongated at their 3\u2018 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057\u20131062","journal-title":"J Gen Virol"},{"key":"1442_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"De","year":"2004","unstructured":"De Villiers EM, Fauquet C, Broker TR et al (2004) Classification of papillomaviruses. Virology 324:17\u201327","journal-title":"Virology"},{"key":"1442_CR11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20050369","volume":"Sci","author":"Doorbar","year":"2006","unstructured":"Doorbar J (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110:525\u2013541","journal-title":"Clin"},{"key":"1442_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.11691","volume":"109","author":"Duensing","year":"2004","unstructured":"Duensing S, Munger K (2004) Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 109:157\u2013162","journal-title":"Int J Cancer"},{"key":"1442_CR13","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1128\/JVI.71.3.2449-2456.1997","volume":"71","author":"Evander","year":"1997","unstructured":"Evander M, Frazer IH, Payne E et al (1997) Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 71:2449\u20132456","journal-title":"J Virol"},{"key":"1442_CR14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.qco.0000199019.50451.a8","volume":"19","author":"Fox","year":"2006","unstructured":"Fox PA (2006) Human papillomavirus and anal intraepithelial neoplasia. Curr Opin Infect Dis 19:62\u201366","journal-title":"Curr Opin Infect Dis"},{"key":"1442_CR15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.virol.2008.10.004","volume":"384","author":"Frazer","year":"2009","unstructured":"Frazer IH (2009) Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology 384:410\u2013414","journal-title":"Virology"},{"key":"1442_CR16","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s00705-006-0821-0","volume":"151","author":"Garnett","year":"2006","unstructured":"Garnett TO, Duerksen-Hughes PJ (2006) Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. Arch Virol 151:2321\u20132335","journal-title":"Arch Virol"},{"key":"1442_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11262-009-0412-8","volume":"40","author":"Ghittoni","year":"2010","unstructured":"Ghittoni R, Accardi R, Hasan U et al (2010) The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 40:1\u201313","journal-title":"Virus Genes"},{"key":"1442_CR18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","volume":"92","author":"Gillison","year":"2000","unstructured":"Gillison ML, Koch WM, Capone RB et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709\u2013720","journal-title":"J Natl Cancer Inst"},{"key":"1442_CR19","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1002\/j.1460-2075.1989.tb08570.x","volume":"8","author":"Hawley-Nelson","year":"1989","unstructured":"Hawley-Nelson P, Vousden KH, Hubbert NL et al (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8:3905\u20133910","journal-title":"EMBO J"},{"key":"1442_CR20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/rmv.488","volume":"16","author":"Hebner","year":"2006","unstructured":"Hebner CM, Laimins LA (2006) Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol 16:83\u201397","journal-title":"Rev Med Virol"},{"key":"1442_CR21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2008.11.017","volume":"384","author":"Howie","year":"2009","unstructured":"Howie HL, Katzenellenbogen RA, Galloway DA (2009) Papillomavirus E6 proteins. Virology 384:324\u2013334","journal-title":"Virology"},{"key":"1442_CR22","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1073\/pnas.92.5.1654","volume":"92","author":"Jeon","year":"1995","unstructured":"Jeon S, Lambert PF (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 92:1654\u20131658","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1442_CR23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/JVI.80.2.759-768.2006","volume":"80","author":"Kamper","year":"2006","unstructured":"Kamper N, Day PM, Nowak T et al (2006) A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 80:759\u2013768","journal-title":"J Virol"},{"key":"1442_CR24","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1128\/JVI.62.6.1917-1924.1988","volume":"62","author":"Kaur","year":"1988","unstructured":"Kaur P, Mcdougall JK (1988) Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J Virol 62:1917\u20131924","journal-title":"J Virol"},{"key":"1442_CR25","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1073\/pnas.0908502106","volume":"106","author":"Kines","year":"2009","unstructured":"Kines RC, Thompson CD, Lowy DR et al (2009) The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U S A 106:20458\u201320463","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1442_CR26","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1158\/0008-5472.CAN-06-1057","volume":"66","author":"Kjaer","year":"2006","unstructured":"Kjaer S, Hogdall E, Frederiksen K et al (2006) The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res 66:10630\u201310636","journal-title":"Cancer Res"},{"key":"1442_CR27","first-page":"6132","volume":"59","author":"Klaes","year":"1999","unstructured":"Klaes R, Woerner SM, Ridder R et al (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59:6132\u20136136","journal-title":"Cancer Res"},{"key":"1442_CR28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00106-004-1069-1","volume":"52","author":"Klussmann","year":"2004","unstructured":"Klussmann JP, Dinh S, Guntinas-Lichius O et al (2004) HPV-associated tonsillar cancer. An update. HNO 52:208\u2013218","journal-title":"HNO"},{"key":"1442_CR29","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/ijc.21961","volume":"119","author":"Lont","year":"2006","unstructured":"Lont AP, Kroon BK, Horenblas S et al (2006) Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 119:1078\u20131081","journal-title":"Int J Cancer"},{"key":"1442_CR30","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/ijc.23446","volume":"122","author":"Madsen","year":"2008","unstructured":"Madsen BS, Jensen HL, Van Den Brule AJ et al (2008) Risk factors for invasive squamous cell carcinoma of the vulva and vagina \u2013 population-based case-control study in Denmark. Int J Cancer 122:2827\u20132834","journal-title":"Int J Cancer"},{"key":"1442_CR31","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4161\/cc.5.14.3094","volume":"5","author":"Mcbride","year":"2006","unstructured":"Mcbride AA, Oliveira JG, Mcphillips MG (2006) Partitioning viral genomes in mitosis: same idea, different targets. Cell Cycle 5:1499\u20131502","journal-title":"Cell Cycle"},{"key":"1442_CR32","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.1073\/pnas.85.19.7169","volume":"85","author":"Mccance","year":"1988","unstructured":"Mccance DJ, Kopan R, Fuchs E et al (1988) Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci U S A 85:7169\u20137173","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1442_CR33","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1128\/JVI.77.19.10186-10201.2003","volume":"77","author":"Middleton","year":"2003","unstructured":"Middleton K, Peh W, Southern S et al (2003) Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol 77:10186\u201310201","journal-title":"J Virol"},{"key":"1442_CR34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","volume":"10","author":"Moody","year":"2010","unstructured":"Moody CA, Laimins LA (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10:550\u2013560","journal-title":"Nat Rev Cancer"},{"key":"1442_CR35","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.1038\/sj.onc.1204860","volume":"20","author":"Munger","year":"2001","unstructured":"Munger K, Basile JR, Duensing S et al (2001) Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888\u20137898","journal-title":"Oncogene"},{"key":"1442_CR36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, De Sanjose S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518\u2013527","journal-title":"N Engl J Med"},{"key":"1442_CR37","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1128\/JVI.75.9.4283-4296.2001","volume":"75","author":"Nees","year":"2001","unstructured":"Nees M, Geoghegan JM, Hyman T et al (2001) Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J Virol 75:4283\u20134296","journal-title":"J Virol"},{"key":"1442_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2008.07.017","volume":"380","author":"Nguyen","year":"2008","unstructured":"Nguyen CL, Munger K (2008) Direct association of the HPV16 E7 oncoprotein with cyclin A\/CDK2 and cyclin E\/CDK2 complexes. Virology 380:21\u201325","journal-title":"Virology"},{"key":"1442_CR39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vaccine.2006.05.111","volume":"24","author":"Parkin","year":"2006","unstructured":"Parkin DM, Bray F (2006) Chapter 2: The burden of HPV-related cancers. Vaccine 24 (Suppl 3):11\u201325","journal-title":"Vaccine"},{"key":"1442_CR40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1006\/viro.1993.1546","volume":"196","author":"Pei","year":"1993","unstructured":"Pei XF, Meck JM, Greenhalgh D et al (1993) Cotransfection of HPV-18 and v-fos DNA induces tumorigenicity of primary human keratinocytes. Virology 196:855\u2013860","journal-title":"Virology"},{"key":"1442_CR41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00292-008-1051-x","volume":"29","author":"Petersen","year":"2008","unstructured":"Petersen I, Klein F (2008) HPV in non-gynecological tumors. Pathologe 29 (Suppl 2):118\u2013122","journal-title":"Pathologe"},{"key":"1442_CR42","doi-asserted-by":"crossref","first-page":"e1000318","DOI":"10.1371\/journal.ppat.1000318","volume":"5","author":"Pyeon","year":"2009","unstructured":"Pyeon D, Pearce SM, Lank SM et al (2009) Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 5:e1000318","journal-title":"PLoS Pathog"},{"key":"1442_CR43","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/jnci\/82.18.1477","volume":"82","author":"Resnick","year":"1990","unstructured":"Resnick RM, Cornelissen MT, Wright DK et al (1990) Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 82:1477\u20131484","journal-title":"J Natl Cancer Inst"},{"key":"1442_CR44","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1073\/pnas.0508815103","volume":"103","author":"Richards","year":"2006","unstructured":"Richards RM, Lowy DR, Schiller JT et al (2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A 103:1522\u20131527","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1442_CR45","first-page":"485","volume":"12","author":"Richardson","year":"2003","unstructured":"Richardson H, Kelsall G, Tellier P et al (2003) The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 12:485\u2013490","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1442_CR46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nm1598","volume":"13","author":"Roberts","year":"2007","unstructured":"Roberts JN, Buck CB, Thompson CD et al (2007) Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 13:857\u2013861","journal-title":"Nat Med"},{"key":"1442_CR47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","volume":"337","author":"Schiffman","year":"2005","unstructured":"Schiffman M, Herrero R, Desalle R et al (2005) The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337:76\u201384","journal-title":"Virology"},{"key":"1442_CR48","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J et al (2007) Human papillomavirus and cervical cancer. Lancet 370:890\u2013907","journal-title":"Lancet"},{"key":"1442_CR49","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ygyno.2010.04.004","volume":"118","author":"Schiller","year":"2010","unstructured":"Schiller JT, Day PM, Kines RC (2010) Current understanding of the mechanism of HPV infection. Gynecol Oncol 118:S12\u2013S17","journal-title":"Gynecol Oncol"},{"key":"1442_CR50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/viro.2001.1493","volume":"299","author":"Selinka","year":"2002","unstructured":"Selinka HC, Giroglou T, Sapp M (2002) Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 299:279\u2013287","journal-title":"Virology"},{"key":"1442_CR51","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1128\/JVI.00998-07","volume":"81","author":"Selinka","year":"2007","unstructured":"Selinka HC, Florin L, Patel HD et al (2007) Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol 81:10970\u201310980","journal-title":"J Virol"},{"key":"1442_CR52","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1158\/0008-5472.CAN-08-3711","volume":"69","author":"Shin","year":"2009","unstructured":"Shin MK, Balsitis S, Brake T et al (2009) Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis. Cancer Res 69:5656\u20135663","journal-title":"Cancer Res"},{"key":"1442_CR53","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B et al (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621\u2013632","journal-title":"Int J Cancer"},{"key":"1442_CR54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.1866","volume":"208","author":"Snijders","year":"2006","unstructured":"Snijders PJ, Steenbergen RD, Heideman DA et al (2006) HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 208:152\u2013164","journal-title":"J Pathol"},{"key":"1442_CR55","first-page":"195","volume":"89","author":"Sotlar","year":"2005","unstructured":"Sotlar K, Diemer D, Stubner A et al (2005) Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN). Verh Dtsch Ges Pathol 89:195\u2013200","journal-title":"Verh Dtsch Ges Pathol"},{"key":"1442_CR56","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jnci\/dji073","volume":"97","author":"Strickler","year":"2005","unstructured":"Strickler HD, Burk RD, Fazzari M et al (2005) Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97:577\u2013586","journal-title":"J Natl Cancer Inst"},{"key":"1442_CR57","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00292-005-0763-4","volume":"26","author":"Trunk","year":"2005","unstructured":"Trunk MJ, Wentzensen N, von Knebel Doeberitz M (2005) Molecular pathogenesis of cervical cancer and its first steps. Pathologe 26:283\u2013290","journal-title":"Pathologe"},{"key":"1442_CR58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"1442_CR59","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","volume":"357","author":"Woodman","year":"2001","unstructured":"Woodman CB, Collins S, Winter H et al (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357:1831\u20131836","journal-title":"Lancet"},{"key":"1442_CR60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","volume":"384","author":"Zur","year":"2009","unstructured":"Zur Hausen H (2009) Papillomaviruses in the causation of human cancers \u2013 a brief historical account. Virology 384:260\u2013265","journal-title":"Virology"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-011-1442-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-011-1442-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-011-1442-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T10:59:10Z","timestamp":1592996350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-011-1442-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["1442"],"URL":"https:\/\/doi.org\/10.1007\/s00292-011-1442-2","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}